A gut-heart connection in cardiometabolic regulation
被引:22
|
作者:
Buglioni, Alessia
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USAMayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA
Buglioni, Alessia
[1
]
Burnett, John C., Jr.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USAMayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA
Burnett, John C., Jr.
[1
]
机构:
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA
ATRIAL-NATRIURETIC-PEPTIDE;
HUMAN ADIPOCYTES;
BLOOD-PRESSURE;
D O I:
10.1038/nm.3196
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
A new study establishes a link between glucagon-like peptide-1 (GLP-1) release from the gut and the cardiac hormone atrial natriuretic peptide, which lowers blood pressure. As GLP-1 receptor agonists are used to control glycemia in patients with type 2 diabetes, this new gut-heart axis suggests a role of these agents in overall cardiovascular homeostasis (pages 567–575).